Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
Toghanian S, Johnson DA, Stålhammar NO, Zerbib F. Toghanian S, et al. Among authors: stalhammar no. Clin Drug Investig. 2011 Oct 1;31(10):703-15. doi: 10.2165/11595480-000000000-00000. Clin Drug Investig. 2011. PMID: 21756007
Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.
Wahlqvist P, Carlsson J, Stålhammar NO, Wiklund I. Wahlqvist P, et al. Among authors: stalhammar no. Value Health. 2002 Mar-Apr;5(2):106-13. doi: 10.1046/j.1524-4733.2002.52101.x. Value Health. 2002. PMID: 11918826 Free article.
On future non-medical costs in economic evaluations.
Liljas B, Karlsson GS, Stålhammar NO. Liljas B, et al. Among authors: stalhammar no. Health Econ. 2008 May;17(5):579-91. doi: 10.1002/hec.1279. Health Econ. 2008. PMID: 17787027
Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.
Bruley des Varannes S, Löfman HG, Karlsson M, Wahlqvist P, Ruth M, Furstnau ML, Despiégel N, Stålhammar NO. Bruley des Varannes S, et al. Among authors: stalhammar no. BMC Gastroenterol. 2013 Feb 28;13:39. doi: 10.1186/1471-230X-13-39. BMC Gastroenterol. 2013. PMID: 23448382 Free PMC article. Clinical Trial.
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA.
Stålhammar NO, Spiegel BM, Granstedt Löfman H, Karlsson M, Wahlqvist P, Næsdal J, Nelson MT, Despiégel N. Stålhammar NO, et al. Pragmat Obs Res. 2012 Dec 5;3:57-67. doi: 10.2147/POR.S36704. eCollection 2012. Pragmat Obs Res. 2012. PMID: 27774018 Free PMC article.
Intradialytic hypotension and risk of cardiovascular disease.
Stefánsson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO. Stefánsson BV, et al. Among authors: stalhammar no. Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2124-32. doi: 10.2215/CJN.02680314. Epub 2014 Nov 6. Clin J Am Soc Nephrol. 2014. PMID: 25376764 Free PMC article.
Contingent valuation with an open-ended follow-up question: a test of scope effects.
Kartman B, Stålhammar NO, Johannesson M. Kartman B, et al. Among authors: stalhammar no. Health Econ. 1997 Nov-Dec;6(6):637-9. doi: 10.1002/(sici)1099-1050(199711)6:6<637::aid-hec314>3.0.co;2-v. Health Econ. 1997. PMID: 9466145
No significant scope effects were detected. It is concluded that the results obtained do not support the use of an open-ended follow-up in contingent valuation applications....
No significant scope effects were detected. It is concluded that the results obtained do not support the use of an open-ended follow-
A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients.
Cabrera C, Brunelli SM, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO, Stefánsson BV. Cabrera C, et al. Among authors: stalhammar no. BMC Nephrol. 2015 Jul 22;16:113. doi: 10.1186/s12882-015-0110-9. BMC Nephrol. 2015. PMID: 26197758 Free PMC article.
Antibiotic research and development: business as usual?
Harbarth S, Theuretzbacher U, Hackett J; DRIVE-AB consortium. Harbarth S, et al. J Antimicrob Chemother. 2015;70(6):1604-7. doi: 10.1093/jac/dkv020. Epub 2015 Feb 10. J Antimicrob Chemother. 2015. PMID: 25673635
Health resource utilization and drug treatment pattern in a cohort of patients with a first episode of gastroesophageal reflux disease.
García Rodríguez LA, Ruigómez A, Wallander MA, Johansson S, Stålhammar NO. García Rodríguez LA, et al. Among authors: stalhammar no. Pharmacoepidemiol Drug Saf. 1999 Dec;8(7):493-500. doi: 10.1002/(SICI)1099-1557(199912)8:7<493::AID-PDS463>3.0.CO;2-O. Pharmacoepidemiol Drug Saf. 1999. PMID: 15073892
19 results
Jump to page
Feedback